A 3-year Study Following up Patients With Moderate to Severe Rheumatoid Arthritis Treated With Humira in Greece
Study Identifier
PMOS GREC 2004 06
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
The objectives of the study are to observe and assess the long-term use, safety and efficacy of Humira (adalimumab), as prescribed by the rheumatologist in a normal clinical setting and in accordance with the terms of the European marketing authorization and to observe compliance of patients with the prescribed treatment.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 30116
A. Glyfada, Greece
Status
Not applicable
Location
Site Reference ID/Investigator# 47544
Ag. Dimitrios, Athens, Greece, 17121
Status
Not applicable
Location
Site Reference ID/Investigator# 47542
Ag. Paraskevi, Athens, Greece, 15343
Status
Not applicable
Location
Site Reference ID/Investigator# 29915
Alexandroupoli, Greece, 68100
Status
Not applicable
Location
Site Reference ID/Investigator# 30118
Arta, Greece, 47100
Status
Not applicable
Location
Site Reference ID/Investigator# 29989
Athens, Greece, 10444
Status
Not applicable
Showing {first} - {last} of {total} Results